{"id":"W1881640566","doi":"10.1016/j.cgh.2014.01.029","title":"A Phase 2 Study of Tofacitinib, an Oral Janus Kinase Inhibitor, in Patients With Crohn’s Disease","year":2014,"lang":"en","type":"article","venue":"Clinical Gastroenterology and Hepatology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":301,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Placebo; Janus kinase inhibitor; Internal medicine; Adverse effect; Gastroenterology; Crohn's disease; Ulcerative colitis; Inflammatory bowel disease; Clinical endpoint; Clinical trial; Phases of clinical research; Disease; Rheumatoid arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004166971,0.0002131963,0.0004506295,0.00007751465,0.000047629,0.00000638714,0.0001786033,0.0001862933,0.0000197111],"category_scores_gemma":[0.0001937526,0.0001877147,0.00006549268,0.00003583996,0.0005149287,0.00001025653,0.0001488177,0.000201933,0.000002401608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005719714,"about_ca_system_score_gemma":0.00006064583,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001365365,"about_ca_topic_score_gemma":0.0008339282,"domain_scores_codex":[0.9973406,0.0009543422,0.0006372748,0.0006128628,0.00009114368,0.0003637494],"domain_scores_gemma":[0.9988599,0.00003396432,0.00019129,0.000474698,0.0001015662,0.0003386268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02667693,0.008496289,0.9632674,0.00001837583,0.00005550144,0.0001860748,0.00003612049,0.000005997415,0.00002539611,0.00002608783,0.00005438402,0.001151443],"study_design_scores_gemma":[0.02465152,0.01660943,0.9581343,0.000007535397,0.00006853158,0.000003322584,0.00004577765,0.0001263287,0.0000100489,0.00003537785,0.0001900212,0.000117788],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9992109,0.00001065762,0.00008052955,0.00004477031,0.000143895,0.0004326737,0.00005255091,0.00001002643,0.00001397825],"genre_scores_gemma":[0.9987667,0.000005075329,0.00009115777,0.0008337274,0.00007014323,0.00004548287,0.0001621506,0.00001900079,0.000006556368],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008113144,"threshold_uncertainty_score":0.7654781,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01401290408214391,"score_gpt":0.3015733751171542,"score_spread":0.2875604710350103,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}